Cargando…

Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Detalles Bibliográficos
Autores principales:	Chen, Xinhua, Zhang, Huimin, Wang, Minghao, Liu, Hao, Hu, Yanfeng, Lin, Tian, Chen, Hao, Zhao, Mingli, Chen, Tao, Li, Guoxin, Yu, Jiang, Zhao, Liying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311409/ https://www.ncbi.nlm.nih.gov/pubmed/37398655 http://dx.doi.org/10.3389/fimmu.2023.1235273

Ejemplares similares

Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients
por: Chen, Xinhua, et al.
Publicado: (2022)

Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastases
por: Liang, Huayuan, et al.
Publicado: (2022)

Development and validation of nomogram of peritoneal metastasis in gastric cancer based on simplified clinicopathological features and serum tumor markers
por: Yang, Jia, et al.
Publicado: (2023)

Application value of overlap guiding tube (OGT) in assisting overlap esophagojejunostomy during laparoscopic total gastrectomy for gastric/gastroesophageal junction (G/GEJ) tumors
por: Xinhua, Chen, et al.
Publicado: (2022)

Safety and short-term outcomes of laparoscopic surgery for advanced gastric cancer after neoadjuvant immunotherapy: A retrospective cohort study
por: Su, Jin, et al.
Publicado: (2022)

Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
por: Liang, Yanrui, et al.
Publicado: (2021)

Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
por: Liang, Yanrui, et al.
Publicado: (2021)

Corrigendum: Programmed cell death and lipid metabolism of macrophages in NAFLD
por: Xiao, Zhun, et al.
Publicado: (2023)

Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity
por: Zheng, Hao, et al.
Publicado: (2022)

Frequency and Prognosis of Pulmonary Metastases in Newly Diagnosed Gastric Cancer
por: Sun, Zepang, et al.
Publicado: (2019)

Diabetes mellitus promoted lymph node metastasis in gastric cancer: a 15–year single-institution experience
por: Chen, Xinhua, et al.
Publicado: (2022)

Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis
por: Li, Jing-Hua, et al.
Publicado: (2018)

Enhanced recovery after surgery in laparoscopic distal gastrectomy: Protocol for a prospective single-arm clinical trial
por: Chen, Xinhua, et al.
Publicado: (2021)

Promotion of Cell Proliferation through Inhibition of Cell Autophagy Signalling Pathway by Rab3IP is Restrained by MicroRNA-532-3p in Gastric Cancer
por: Guo, Weihong, et al.
Publicado: (2018)

Clinicopathological Significance of NMIIA Overexpression in Human Gastric Cancer
por: Liu, Dongning, et al.
Publicado: (2012)

Liver Metastases in Newly Diagnosed Gastric Cancer: A Population-Based Study from SEER
por: Sun, Zepang, et al.
Publicado: (2019)

Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score‐matched analysis
por: Geng, Xiuwen, et al.
Publicado: (2016)

Genomics Score Based on Genome-Wide Network Analysis for Prediction of Survival in Gastric Cancer: A Novel Prognostic Signature
por: Sun, Zepang, et al.
Publicado: (2020)

Association of the programmed death ligand‐1 combined positive score in tumors and clinicopathological features in esophageal cancer
por: Huang, Ziling, et al.
Publicado: (2021)

Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells
por: Wang, Qianqian, et al.
Publicado: (2022)

Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy
por: Chen, Xinhua, et al.
Publicado: (2020)

Comparison study of clinicopathological features of cellular schwannoma between retroperitoneum and other sites
por: Zhang, Xiaoying, et al.
Publicado: (2022)

Clinicopathological features and differential diagnosis of gastric metastases
por: Chen, Wen, et al.
Publicado: (2023)

Implications of clinical research on adjuvant chemotherapy for gastric cancer: Where to go next?
por: Chen, Xinhua, et al.
Publicado: (2019)

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy
por: Jiang, Yao, et al.
Publicado: (2023)

Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
por: She, Shaoping, et al.
Publicado: (2022)

Circ-104916 is downregulated in gastric cancer and suppresses migration and invasion of gastric cancer cells
por: Li, Jin, et al.
Publicado: (2017)

Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer
por: Zhao, Fujun, et al.
Publicado: (2012)

Corrigendum: TACI Isoforms Regulate Ligand Binding and Receptor Function
por: Garcia-Carmona, Yolanda, et al.
Publicado: (2019)

Enhanced recovery after surgery for laparoscopic gastrectomy in gastric cancer: A prospective study
por: Liang, Yanrui, et al.
Publicado: (2021)

Computed Tomography Features and Clinicopathological Characteristics of Gastric Sarcomatoid Carcinoma
por: Liu, Yi-yang, et al.
Publicado: (2020)

Corrigendum: Potential gut microbiota features for non-invasive detection of schistosomiasis
por: Lin, Datao, et al.
Publicado: (2022)

PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer
por: Huang, Weicai, et al.
Publicado: (2022)

Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death”
por: Bezu, Lucillia, et al.
Publicado: (2015)

Programmed cell death and lipid metabolism of macrophages in NAFLD
por: Xiao, Zhun, et al.
Publicado: (2023)

Clinicopathological Features of Programmed Cell Death-ligand 1 Expression in Patients with Oral Squamous Cell Carcinoma
por: Cui, Yong-Xin, et al.
Publicado: (2020)

Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder
por: Nie, Guangyan, et al.
Publicado: (2022)

The Clinicopathological Characteristics and Prognoses of dMMR Gastric Adenocarcinoma Patients
por: Wang, Jie, et al.
Publicado: (2021)

Corrigendum: Construction and validation of a robust prognostic model based on immune features in sepsis
por: Zheng, Yongxin, et al.
Publicado: (2023)

Soluble monomeric human programmed cell death-ligand 1 inhibits the functions of activated T cells
por: Liang, Zhaoduan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fdd00ovhsdnonni7ho139t2928